Exozymes Inc.
EXOZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002010788
In the last 90 days, Exozymes Inc. insiders filed 1 open-market purchase and 0 sales; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.05M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Exozymes Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 6 | 7 | +1 |
| Shares | 59.9K | 62.6K | +2.68K (+4.5%) |
| Value | $880.4K | $682.4K | −$198.0K (−22.5%) |
New holders (1)
Institutions that held Exozymes Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 2 | $22 | 0.00% |
Sold out (0)
Institutions that held Exozymes Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
None.